PDB Short entry for 3L3L HEADER TRANSFERASE/TRANSFERASE INHIBITOR 17-DEC-09 3L3L TITLE PARP COMPLEXED WITH A906894 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 662-1011; COMPND 5 SYNONYM: PARP-1, ADPRT, NAD(+) ADP-RIBOSYLTRANSFERASE 1, POLY[ADP- COMPND 6 RIBOSE] SYNTHETASE 1; COMPND 7 EC: 2.4.2.30; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP1, ADPRT, PPOL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN-INHIBITOR COMPLEX, ADP-RIBOSYLATION, DNA DAMAGE, DNA REPAIR, KEYWDS 2 DNA-BINDING, GLYCOSYLTRANSFERASE, METAL-BINDING, NAD, NUCLEUS, KEYWDS 3 PHOSPHOPROTEIN, TRANSCRIPTION, TRANSCRIPTION REGULATION, KEYWDS 4 TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.H.PARK REVDAT 5 03-APR-24 3L3L 1 REMARK REVDAT 4 21-FEB-24 3L3L 1 REMARK REVDAT 3 13-OCT-21 3L3L 1 REMARK SEQADV REVDAT 2 29-DEC-10 3L3L 1 HEADER REVDAT 1 22-DEC-10 3L3L 0 JRNL AUTH V.B.GANDHI,Y.LUO,X.LIU,Y.SHI,V.KLINGHOFER,E.F.JOHNSON, JRNL AUTH 2 C.PARK,V.L.GIRANDA,T.D.PENNING,G.D.ZHU JRNL TITL DISCOVERY AND SAR OF SUBSTITUTED JRNL TITL 2 3-OXOISOINDOLINE-4-CARBOXAMIDES AS POTENT INHIBITORS OF JRNL TITL 3 POLY(ADP-RIBOSE) POLYMERASE (PARP) FOR THE TREATMENT OF JRNL TITL 4 CANCER. JRNL REF BIOORG.MED.CHEM.LETT. V. 20 1023 2010 JRNL REFN ISSN 0960-894X JRNL PMID 20045315 JRNL DOI 10.1016/J.BMCL.2009.12.042 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 3 NUMBER OF REFLECTIONS : 12000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 583 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.65 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 68.40 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1341 REMARK 3 BIN R VALUE (WORKING SET) : 0.2480 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 84 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.043 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2751 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 19 REMARK 3 SOLVENT ATOMS : 80 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -11.42000 REMARK 3 B22 (A**2) : -11.42000 REMARK 3 B33 (A**2) : 22.83000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.340 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3L3L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-JAN-10. REMARK 100 THE DEPOSITION ID IS D_1000056789. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-OCT-05 REMARK 200 TEMPERATURE (KELVIN) : 110.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NOT SURE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12000 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 81.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.11100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.74000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: INHOUSE PARP-A904051 STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION : PARP 60 MG/ML IN 50 REMARK 280 MM TRIS, 150 MM NACL, 1.5 MM DTT PH 7.5, 2MM A861146 WELL REMARK 280 SOLUTION : 0.8 M NACL, 1.8 M AMMONIUM SULFATE CRYSTALS ARE REMARK 280 SOAKED IN WELL SOLUTION CONTAINING 1MM A906894 FROM 0.1 M DMSO REMARK 280 STOCK CRYOPROTECTANT : 1.2 M NACL, 1.6 M AMMONIUM SULFATE, 20 % REMARK 280 ETHYLENE GLYCOL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15810 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 83890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -57.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 162.85261 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -141.03450 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 81.42631 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 -0.500000 0.866025 0.000000 -141.03450 REMARK 350 BIOMT2 4 0.866025 0.500000 0.000000 81.42631 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 68.77300 REMARK 350 BIOMT1 5 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 5 0.000000 -1.000000 0.000000 162.85261 REMARK 350 BIOMT3 5 0.000000 0.000000 -1.000000 68.77300 REMARK 350 BIOMT1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 6 0.000000 0.000000 -1.000000 68.77300 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NE2 GLN A 192 NE2 GLN A 192 6555 1.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 128 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 PRO A 128 C - N - CD ANGL. DEV. = -17.2 DEGREES REMARK 500 PRO A 254 C - N - CA ANGL. DEV. = 12.1 DEGREES REMARK 500 PRO A 254 C - N - CD ANGL. DEV. = -12.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 65 -175.58 39.41 REMARK 500 SER A 66 -52.66 64.12 REMARK 500 LYS A 86 -8.27 78.94 REMARK 500 LYS A 87 151.60 71.39 REMARK 500 LEU A 117 -9.00 -58.05 REMARK 500 ASP A 122 36.89 -93.34 REMARK 500 ASP A 123 -159.82 -62.75 REMARK 500 ALA A 162 -145.53 -111.48 REMARK 500 HIS A 165 20.98 -140.48 REMARK 500 ASN A 166 56.48 -64.73 REMARK 500 GLU A 183 82.74 -65.66 REMARK 500 CYS A 184 -57.04 178.96 REMARK 500 HIS A 194 -179.99 -63.98 REMARK 500 HIS A 248 76.63 41.22 REMARK 500 SER A 275 106.51 -166.55 REMARK 500 ILE A 277 -74.01 -127.62 REMARK 500 SER A 278 -45.65 71.86 REMARK 500 ASP A 296 109.79 -50.48 REMARK 500 LEU A 303 132.01 159.50 REMARK 500 ASP A 304 -19.31 66.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L3L A 351 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2RCW RELATED DB: PDB REMARK 900 PARP-A620223 REMARK 900 RELATED ID: 2RD6 RELATED DB: PDB REMARK 900 PARP-A61695 REMARK 900 RELATED ID: 3GJW RELATED DB: PDB REMARK 900 PARP-A968427 REMARK 900 RELATED ID: 3GN7 RELATED DB: PDB REMARK 900 PARP-A861696 DBREF 3L3L A 1 350 UNP P09874 PARP1_HUMAN 662 1011 SEQADV 3L3L ALA A 101 UNP P09874 VAL 762 ENGINEERED MUTATION SEQRES 1 A 350 LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU ILE LYS SEQRES 2 A 350 MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA MET VAL SEQRES 3 A 350 GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU GLY LYS SEQRES 4 A 350 LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER ILE LEU SEQRES 5 A 350 SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SER ASP SEQRES 6 A 350 SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR THR LEU SEQRES 7 A 350 ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO LEU LEU SEQRES 8 A 350 ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU MET LEU SEQRES 9 A 350 ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER LEU LEU SEQRES 10 A 350 ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO ILE ASP SEQRES 11 A 350 VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS VAL VAL SEQRES 12 A 350 ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG LYS TYR SEQRES 13 A 350 VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA TYR ASP SEQRES 14 A 350 LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG GLU GLY SEQRES 15 A 350 GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU HIS ASN SEQRES 16 A 350 ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR ASN PHE SEQRES 17 A 350 ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA PRO PRO SEQRES 18 A 350 GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS GLY ILE SEQRES 19 A 350 TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN TYR CYS SEQRES 20 A 350 HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE LEU LEU SEQRES 21 A 350 GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU LYS HIS SEQRES 22 A 350 ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS HIS SER SEQRES 23 A 350 VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SER ALA SEQRES 24 A 350 ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU GLY THR SEQRES 25 A 350 GLY ILE SER SER GLY VAL ASN ASP THR SER LEU LEU TYR SEQRES 26 A 350 ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL ASN LEU SEQRES 27 A 350 LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS THR HET L3L A 351 19 HETNAM L3L 3-OXO-2-PIPERIDIN-4-YL-2,3-DIHYDRO-1H-ISOINDOLE-4- HETNAM 2 L3L CARBOXAMIDE FORMUL 2 L3L C14 H17 N3 O2 FORMUL 3 HOH *80(H2 O) HELIX 1 1 PRO A 5 PHE A 16 1 12 HELIX 2 2 ASP A 17 GLU A 27 1 11 HELIX 3 3 PRO A 36 LEU A 40 5 5 HELIX 4 4 SER A 41 GLY A 62 1 22 HELIX 5 5 SER A 66 ILE A 79 1 14 HELIX 6 6 ASN A 93 ARG A 118 1 26 HELIX 7 7 ASP A 127 LEU A 136 1 10 HELIX 8 8 SER A 147 THR A 160 1 14 HELIX 9 9 TYR A 187 GLN A 192 1 6 HELIX 10 10 ARG A 204 THR A 206 5 3 HELIX 11 11 ASN A 207 GLY A 215 1 9 HELIX 12 12 MET A 239 ALA A 244 1 6 HELIX 13 13 ASN A 245 CYS A 247 5 3 HELIX 14 14 PRO A 297 ASN A 300 5 4 HELIX 15 15 ASP A 332 ALA A 334 5 3 SHEET 1 A 5 THR A 138 VAL A 142 0 SHEET 2 A 5 TYR A 168 ARG A 180 -1 O GLU A 179 N ASP A 139 SHEET 3 A 5 VAL A 336 PHE A 348 -1 O LYS A 339 N ILE A 178 SHEET 4 A 5 ILE A 255 ALA A 264 -1 N GLU A 262 O ASN A 337 SHEET 5 A 5 ARG A 196 SER A 203 -1 N HIS A 201 O LEU A 259 SHEET 1 B 4 ILE A 234 PHE A 236 0 SHEET 2 B 4 GLU A 327 VAL A 330 -1 O VAL A 330 N ILE A 234 SHEET 3 B 4 SER A 286 GLY A 289 -1 N GLY A 289 O GLU A 327 SHEET 4 B 4 MET A 268 LEU A 271 1 N TYR A 269 O SER A 286 SHEET 1 C 3 GLY A 313 SER A 315 0 SHEET 2 C 3 GLY A 291 PRO A 295 -1 N THR A 294 O ILE A 314 SHEET 3 C 3 LEU A 323 TYR A 325 1 O LEU A 324 N THR A 293 SITE 1 AC1 9 HIS A 201 GLY A 202 GLY A 227 TYR A 235 SITE 2 AC1 9 LYS A 242 SER A 243 TYR A 246 GLU A 327 SITE 3 AC1 9 HOH A 406 CRYST1 94.023 94.023 68.773 90.00 90.00 120.00 P 3 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010636 0.006141 0.000000 0.00000 SCALE2 0.000000 0.012281 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014541 0.00000